Vanderbilt-ingram Cancer Center

This early-phase study tested a new drug (TGR-1202) combined with an existing treatment (ruxolitinib) in 60 adults with myelofibrosis or polycythemia vera that stopped responding to standard care. The main goal was to check safety and find the best dose. This is not a cure, but a…

This study tested a personalized approach to help people quit smoking by matching medication to their nicotine metabolism. 606 adults on Medicaid or Medicare who smoked daily took part. The goal was to see if tailoring treatment improves quit rates.

This early-phase study tested whether a 2-week very low-carbohydrate (ketogenic) diet combined with the drug letrozole is feasible and tolerable for people with early-stage estrogen receptor-positive (ER+) breast cancer. 31 postmenopausal women participated before surgery. The go…

This study looked at 288 people with a lung nodule needing a biopsy. It compared two procedures: CT-guided biopsy, which goes through the chest wall, and navigation bronchoscopy, which goes through the airways. The goal was to see which method gives a more accurate diagnosis with…